GAST and gastric neuroendocrine tumor, well differentiated, low or intermediate grade: In a previous study, it was found that employing a pepsinogen I/II ratio below 2.3 and gastrin-17 levels exceeding 29.6 pmol/L serves as a definitive approach to distinguish autoimmune gastritis patients with gastric neuroendocrine tumors from those without [55].